144 related articles for article (PubMed ID: 29664840)
1. Malignant Ascites: Validation of a Novel Ascites Symptom Mini-Scale for Use in Patients With Ovarian Cancer.
Eitan R; Raban O; Tsoref D; Jakobson-Setton A; Sabah G; Salman L; Yeoshua E; Ben-Haroush A
Int J Gynecol Cancer; 2018 Jul; 28(6):1162-1166. PubMed ID: 29664840
[TBL] [Abstract][Full Text] [Related]
2. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites.
Easson AM; Bezjak A; Ross S; Wright JG
Ann Surg Oncol; 2007 Aug; 14(8):2348-57. PubMed ID: 17505860
[TBL] [Abstract][Full Text] [Related]
3. Malignant ascites symptom cluster in patients referred for paracentesis.
Husain A; Bezjak A; Easson A
Ann Surg Oncol; 2010 Feb; 17(2):461-9. PubMed ID: 19866240
[TBL] [Abstract][Full Text] [Related]
4. Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone.
Wimberger P; Gilet H; Gonschior AK; Heiss MM; Moehler M; Oskay-Oezcelik G; Al-Batran SE; Schmalfeldt B; Schmittel A; Schulze E; Parsons SL
Ann Oncol; 2012 Aug; 23(8):1979-1985. PubMed ID: 22734013
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.
Hanada R; Yokomichi N; Kato C; Miki K; Oyama S; Morita T; Kawahara R
Support Care Cancer; 2018 May; 26(5):1489-1497. PubMed ID: 29168037
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites.
Neijenhuis M; Gevers TJG; Atwell TD; Gunneson TJ; Schimek AC; Kievit W; Drenth JPH; Kamath PS
Am J Gastroenterol; 2018 Apr; 113(4):567-575. PubMed ID: 29557942
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal pressures and clinical parameters of total paracentesis for palliation of symptomatic ascites in ovarian cancer.
Gotlieb WH; Feldman B; Feldman-Moran O; Zmira N; Kreizer D; Segal Y; Elran E; Ben-Baruch G
Gynecol Oncol; 1998 Dec; 71(3):381-5. PubMed ID: 9887235
[TBL] [Abstract][Full Text] [Related]
8. Paracentesis in ovarian cancer: a study of the physiology during free drainage of ascites.
Decruze SB; Macdonald R; Smith G; Herod JJ
J Palliat Med; 2010 Mar; 13(3):251-4. PubMed ID: 19929225
[TBL] [Abstract][Full Text] [Related]
9. Is Low Volume Drainage of Ascites Associated With Improved Survival in Digestive System Cancer Patients With Malignant Ascites?-A Retrospective Cohort Study.
Hoshino S; Takagi Y; Fukagawa T; Sano K; Seki N; Hashiguchi Y; Aruga E
J Palliat Care; 2023 Oct; 38(4):473-480. PubMed ID: 37093798
[No Abstract] [Full Text] [Related]
10. REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer.
Sjoquist KM; Espinoza D; Mileshkin L; Ananda S; Shannon C; Yip S; Goh J; Bowtell D; Harrison M; Friedlander ML
Gynecol Oncol; 2021 May; 161(2):374-381. PubMed ID: 33637349
[TBL] [Abstract][Full Text] [Related]
11. Assessment of False-negative Ascites Cytology in Epithelial Ovarian Carcinoma: A Study of 313 Patients.
Allen VA; Takashima Y; Nayak S; Manahan KJ; Geisler JP
Am J Clin Oncol; 2017 Apr; 40(2):175-177. PubMed ID: 25198110
[TBL] [Abstract][Full Text] [Related]
12. A survey of treatment approaches of malignant ascites in Germany and Austria.
Jehn CF; Küpferling S; Oskay-Özcelik G; Lüftner D
Support Care Cancer; 2015 Jul; 23(7):2073-8. PubMed ID: 25528551
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal catheter site metastasis in a patient with advanced ovarian cancer.
Ramirez I; Bansal N; Hoffman M
Am J Hosp Palliat Care; 2012 May; 29(3):241-2. PubMed ID: 21606122
[TBL] [Abstract][Full Text] [Related]
14. Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer.
Harding V; Fenu E; Medani H; Shaboodien R; Ngan S; Li HK; Burt R; Diamantis N; Tuthill M; Blagden S; Gabra H; Urch CE; Moser S; Agarwal R
Br J Cancer; 2012 Sep; 107(6):925-30. PubMed ID: 22878372
[TBL] [Abstract][Full Text] [Related]
15. Management of non-ovarian cancer malignant ascites through indwelling catheter drainage.
Gu X; Zhang Y; Cheng M; Liu M; Zhang Z; Cheng W
BMC Palliat Care; 2016 Apr; 15():44. PubMed ID: 27103467
[TBL] [Abstract][Full Text] [Related]
16. The Role of Ultrasound-Guided Therapeutic Paracentesis in an Outpatient Transitional Care Program: A Case Series.
Wang J; Khan S; Wyer P; Vanderwilp J; Reynolds J; Bethancourt B; Ota KS
Am J Hosp Palliat Care; 2018 Sep; 35(9):1256-1260. PubMed ID: 29400065
[TBL] [Abstract][Full Text] [Related]
17. Pattern and prognostic factors in patients with malignant ascites: a retrospective study.
Ayantunde AA; Parsons SL
Ann Oncol; 2007 May; 18(5):945-9. PubMed ID: 17298959
[TBL] [Abstract][Full Text] [Related]
18. Repeat Large-Volume Paracentesis Versus Tunneled Peritoneal Catheter Placement for Malignant Ascites: A Cost-Minimization Study.
Bohn KA; Ray CE
AJR Am J Roentgenol; 2015 Nov; 205(5):1126-34. PubMed ID: 26496562
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer and ascites: A questionnaire on current management in the United kingdom.
Macdonald R; Kirwan J; Roberts S; Gray D; Allsopp L; Green J
J Palliat Med; 2006 Dec; 9(6):1264-70. PubMed ID: 17187534
[TBL] [Abstract][Full Text] [Related]
20. Pocket ultrasound device as a complement to physical examination for ascites evaluation and guided paracentesis.
Keil-Ríos D; Terrazas-Solís H; González-Garay A; Sánchez-Ávila JF; García-Juárez I
Intern Emerg Med; 2016 Apr; 11(3):461-6. PubMed ID: 26895032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
